Unknown

Dataset Information

0

Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients.


ABSTRACT: Long non-coding RNAs are defined as transcripts larger than 200 nucleotides but without protein-coding potential. There is growing evidence of the important role of long non-coding RNAs in cancer initiation, development and progression. In this study, we sought to evaluate the long non-coding RNA expression profile of patients with cytogenetically normal acute myeloid leukemia (AML). RNA-sequencing of 40 cytogenetically normal AML patients allowed us to quantify 11,036 long non-coding RNAs. Among these, more than 8000 were previously undescribed long non-coding RNAs. Using unsupervised analysis, we observed a specific long non-coding RNA expression profile dependent on the mutational status of the NPM1 gene. Statistical analysis allowed us to identify a minimal set of 12 long non-coding RNAs capable of discriminating NPM1-mutated from NPM1-wild-type patients. These results were validated by qRT-PCR on an independent cohort composed of 134 cytogenetically normal AML patients. Furthermore, we have identified one putative biomarker, the long non-coding RNA XLOC_109948 whose expression pattern predicts clinical outcome. Interestingly, low XLOC_109948 expression indicates a good prognosis especially for NPM1-mutated patients. Transient transfection of GapmeR against XLOC_109948 in NPM1-mutated OCI-AML3 cell line treated with Ara-C or ATRA enhances apoptosis suggesting XLOC_109948 plays a role in drug sensitivity. This study improves our knowledge of the long non-coding RNA transcriptome in cytogenetically normal AML patients. We observed a distinct long non-coding RNA expression profile in patients with the NPM1 mutation. The newly identified XLOC_109948 long non-coding RNA emerged as a strong prognostic factor able to better stratify NPM1-mutated patients.

SUBMITTER: De Clara E 

PROVIDER: S-EPMC5622856 | biostudies-other | 2017 Oct

REPOSITORIES: biostudies-other

altmetric image

Publications

Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients.

De Clara Etienne E   Gourvest Morgane M   Ma Hanjing H   Vergez François F   Tosolini Marie M   Dejean Sébastien S   Demur Cécile C   Delabesse Eric E   Recher Christian C   Touriol Christian C   Martelli Maria Paola MP   Falini Brunangelo B   Brousset Pierre P   Bousquet Marina M  

Haematologica 20170704 10


Long non-coding RNAs are defined as transcripts larger than 200 nucleotides but without protein-coding potential. There is growing evidence of the important role of long non-coding RNAs in cancer initiation, development and progression. In this study, we sought to evaluate the long non-coding RNA expression profile of patients with cytogenetically normal acute myeloid leukemia (AML). RNA-sequencing of 40 cytogenetically normal AML patients allowed us to quantify 11,036 long non-coding RNAs. Amon  ...[more]

Similar Datasets

| S-EPMC7659109 | biostudies-literature
| S-EPMC6877618 | biostudies-literature
2019-10-16 | PXD015520 | Pride
| S-EPMC4503761 | biostudies-literature
2013-05-30 | E-GEOD-46951 | biostudies-arrayexpress
| S-EPMC4201902 | biostudies-literature
2013-05-30 | GSE46951 | GEO
| S-EPMC8007823 | biostudies-literature